Ryan Ungaro

About Ryan Ungaro

Ryan Ungaro, With an exceptional h-index of 43 and a recent h-index of 40 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Early intervention, biomarkers, risk stratification, precision medicine.

His recent articles reflect a diverse array of research interests and contributions to the field:

P509 Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn’s disease

Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium

P420 Natural history of intra-abdominal inflammatory masses (phlegmons) in Crohn’s disease

DOP33 Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease

Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies

Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis

P439 Mild Crohn’s disease is characterized by a unique serum metabolomic signature

DOP68 Natural history of isolated Crohn's Disease perianal fistula

Ryan Ungaro Information

University

Position

___

Citations(all)

7542

Citations(since 2020)

6664

Cited By

2648

hIndex(all)

43

hIndex(since 2020)

40

i10Index(all)

107

i10Index(since 2020)

104

Email

University Profile Page

Google Scholar

Ryan Ungaro Skills & Research Interests

Early intervention

biomarkers

risk stratification

precision medicine

Top articles of Ryan Ungaro

P509 Upadacitinib improves symptomatic responses in patients with moderately to severely active Crohn’s disease

Journal of Crohn's and Colitis

2024/1/1

Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium

Inflammatory Bowel Diseases

2024/3/26

P420 Natural history of intra-abdominal inflammatory masses (phlegmons) in Crohn’s disease

Journal of Crohn's and Colitis

2024/1/1

DOP33 Distinct perturbances in metabolic pathways associate with disease progression in patients with Inflammatory Bowel Disease

Journal of Crohn's and Colitis

2024/1/1

Shorter Crohn’s Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies

Gastro Hep Advances

2024/3/7

Problem with Hookups: Perianal Fistula After Ileal Pouch-Anal Anastomosis

Digestive Diseases and Sciences

2024/3/6

Ryan Ungaro
Ryan Ungaro

H-Index: 23

P439 Mild Crohn’s disease is characterized by a unique serum metabolomic signature

Journal of Crohn's and Colitis

2024/1/1

DOP68 Natural history of isolated Crohn's Disease perianal fistula

Journal of Crohn's and Colitis

2024/1/1

Clinical Long-Term Outcomes of Patient-Reported Outcomes in the Prospective Real-World Tofacitinib Response in Ulcerative Colitis Registry

Clinical and translational gastroenterology

2024/3/1

Defining Endoscopic Remission in Crohn’s Disease: MM-SES-CD and SES-CD Thresholds Associated with Low Risk of Disease Progression

Clinical Gastroenterology and Hepatology

2024/2/28

DOP05 Bowel damage and its correlation with the disability index in patients with recently diagnosed Crohn´ s Disease

Journal of Crohn's and Colitis

2024/1/1

Long-Term Effectiveness and Durability of COVID-19 Vaccination among Patients with Inflammatory Bowel Disease

Clinical Gastroenterology and Hepatology

2024/2/17

P226 Disability in Crohn’s Disease Patients at diagnosis: Findings from the CROCO (Crohn´ s Disease Cohort) study

Journal of Crohn's and Colitis

2024/1/1

P683 Economic impact of achieving mucosal healing on UC-related hospitalisations and work productivity in patients with moderately to severely active UC: A post-hoc analysis of …

Journal of Crohn's and Colitis

2024/1/1

Humoral immune response and safety of SARS‐CoV‐2 vaccination in very early onset inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

2024/2/14

Early Use of Biologics Reduces Healthcare Costs in Crohn’s Disease: Results from a United States Population-Based Cohort

Digestive Diseases and Sciences

2024/1

Methods of monitoring inflammatory bowel diseases

2024/2/8

DEVELOPMENT OF CROHN'S DISEASE IN PATIENT PRESENTING WITH COMPLEX PERIANAL FISTULA TO A TERTIARY MEDICAL CARE CENTER

2024/2/1

Ryan Ungaro
Ryan Ungaro

H-Index: 23

INCREASING ACCESS TO INTERDISCIPLINARY IBD CARE FOR NEWLY DIAGNOSED IBD PATIENTS USING TELEMEDICINE: AN EXTENSION OF THE COMPASS-IBD PROGRAM

Gastroenterology

2024/2/1

Perceptions of patients with Inflammatory Bowel Disease and first degree relatives on prediction and prevention of disease

Inflammatory bowel diseases

2015/1/1

See List of Professors in Ryan Ungaro University(Icahn School of Medicine at Mount Sinai)